Discover
SNDX
Syndax Pharmaceuticals, Inc.
20.89
2 x 15.75
2 x 26.84
bid
ask
-
0.97
4.44%
2 @ 04:00 PM
20.51 -0.38 (1.84%)
| Ytd | -0.57% | |
| 1y | 136.85% |
20.70
day range
22.29
8.59
52 week range
25.59
| Open | 22.02 | Prev Close | 21.86 | Low | 20.70 | High | 22.29 | Mkt Cap | 1.85B |
| Vol | 2.14M | Avg Vol | 1.84M | EPS | -2.79 | P/E | N/A | Forward P/E | -41.79 |
| Beta | 0.39 | Short Ratio | 11.70 | Inst. Own | 116.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 19.87 | 200-d Avg | 19.67 | 1yr Est | 39.00 |
| Income Statement | |||
| Total Revenue | 64.86M | ||
| Revenues (USD) | 64.86M | ||
| Cost of Revenue | 2.63M | ||
| Gross Profit | 62.23M | ||
| Operating Expenses | 96.43M | ||
| Research and Development Expense | 58.85M | ||
| Selling, General and Administrative Expense | 37.59M | ||
| Operating Income | -34.20M | ||
| Interest Expense | 11.85M | ||
| Net Income | -42.67M | ||
| Net Income Common Stock | -42.67M | ||
| Net Income Common Stock (USD) | -42.67M | ||
| Consolidated Income | -42.67M | ||
| Earnings per Basic Share | -0.48 | ||
| Earnings per Basic Share (USD) | -0.48 | ||
| Earnings per Diluted Share | -0.48 | ||
| Earning Before Interest & Taxes (EBIT) | -30.83M | ||
| Earning Before Interest & Taxes (USD) | -30.83M | ||
| Weighted Average Shares | 88.26M | ||
| Weighted Average Shares Diluted | 88.26M | ||
| Balance Sheet | |||
| Cash and Equivalents | 131.00M | ||
| Cash and Equivalents (USD) | 131.00M | ||
| Investments | 230.35M | ||
| Investments Current | 230.35M | ||
| Trade and Non-Trade Receivables | 58.89M | ||
| Current Assets | 471.18M | ||
| Property, Plant & Equipment Net | 1.39M | ||
| Total Assets | 472.67M | ||
| Debt Current | 488.00K | ||
| Total Debt | 345.36M | ||
| Current Liabilities | 86.17M | ||
| Debt Non-Current | 344.87M | ||
| Total Liabilities | 431.05M | ||
| Accumulated Retained Earnings (Deficit) | -1.55B | ||
| Accumulated Other Comprehensive Income | 11.00K | ||
| Shareholders Equity | 41.62M | ||
| Shareholders Equity (USD) | 41.62M | ||
| Assets Non-Current | 1.49M | ||
| Total Debt (USD) | 345.36M | ||
| Inventory | 34.95M | ||
| Liabilities Non-Current | 344.87M | ||
| Trade and Non-Trade Payables | 10.84M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 134.00K | ||
| Net Cash Flow from Financing | 7.92M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.04M | ||
| Issuance (Purchase) of Equity Shares | 7.92M | ||
| Net Cash Flow from Investing | 38.39M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 38.39M | ||
| Net Cash Flow from Operations | -50.34M | ||
| Share Based Compensation | 12.05M | ||